ribavirin has been researched along with estradiol 3-benzoate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Ding, JX; Hou, YB; Li, J; Li, RR; Rong, R; Yang, Y; Zhang, CB | 1 |
2 other study(ies) available for ribavirin and estradiol 3-benzoate
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Mahuang-Xixin-Fuzi decoction reduces the infection of influenza A virus in Kidney-Yang deficiency syndrome mice.
Topics: Administration, Oral; Animals; Antioxidants; Antiviral Agents; Chemokine CCL2; Disease Models, Animal; Drugs, Chinese Herbal; Estradiol; Inflammation Mediators; Influenza A Virus, H1N1 Subtype; Interleukin-6; Kidney Diseases; Lung; Malondialdehyde; Mice; Orthomyxoviridae Infections; Pulmonary Edema; Ribavirin; Superoxide Dismutase; Time Factors; Tumor Necrosis Factor-alpha; Yang Deficiency | 2016 |